These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24173639)

  • 1. Bioactive activities of natural products against herpesvirus infection.
    Son M; Lee M; Sung GH; Lee T; Shin YS; Cho H; Lieberman PM; Kang H
    J Microbiol; 2013 Oct; 51(5):545-51. PubMed ID: 24173639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Products and Their Derivatives against Human Herpesvirus Infection.
    Ruchawapol C; Yuan M; Wang SM; Fu WW; Xu HX
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive natural products with anti-herpes simplex virus properties.
    Hassan ST; Masarčíková R; Berchová K
    J Pharm Pharmacol; 2015 Oct; 67(10):1325-36. PubMed ID: 26060043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
    Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of protein kinase inhibitors for treating herpesvirus-associated disease.
    Li R; Hayward SD
    Trends Microbiol; 2013 Jun; 21(6):286-95. PubMed ID: 23608036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-spectrum non-nucleoside inhibitors of human herpesviruses.
    McClain L; Zhi Y; Cheng H; Ghosh A; Piazza P; Yee MB; Kumar S; Milosevic J; Bloom DC; Arav-Boger R; Kinchington PR; Yolken R; Nimgaonkar V; D'Aiuto L
    Antiviral Res; 2015 Sep; 121():16-23. PubMed ID: 26079681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
    Marcelletti JF
    Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
    DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
    mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA encapsidation as a target for anti-herpesvirus drug therapy.
    Visalli RJ; van Zeijl M
    Antiviral Res; 2003 Jul; 59(2):73-87. PubMed ID: 12895691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.
    Liu X; Cohen JI
    Virology; 2015 May; 479-480():568-77. PubMed ID: 25798530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra.
    Topalis D; Gillemot S; Snoeck R; Andrei G
    Drug Resist Updat; 2018 Mar; 37():1-16. PubMed ID: 29548479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections.
    Asha K; Sharma-Walia N
    Front Cell Infect Microbiol; 2021; 11():603309. PubMed ID: 33816328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of herpesvirus infections.
    Evans CM; Kudesia G; McKendrick M
    Int J Antimicrob Agents; 2013 Aug; 42(2):119-28. PubMed ID: 23820015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small RNAs growing tall: miRNAs as drug targets in herpesvirus infections.
    L'Hernault A; Dölken L
    Curr Opin Virol; 2015 Dec; 15():41-7. PubMed ID: 26256575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.
    Gilbert C; Bestman-Smith J; Boivin G
    Drug Resist Updat; 2002 Apr; 5(2):88-114. PubMed ID: 12135584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA helicase-primase complex as a target for herpes viral infection.
    Weller SK; Kuchta RD
    Expert Opin Ther Targets; 2013 Oct; 17(10):1119-32. PubMed ID: 23930666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.
    Šudomová M; Berchová-Bímová K; Marzocco S; Liskova A; Kubatka P; Hassan STS
    Viruses; 2021 May; 13(6):. PubMed ID: 34071559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.